Sofia Doulkeridou
Impact in
-
- Nanoparticle-Based Drug Delivery
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
-
- Glycosylation and Glycoproteins Research 3
- Advanced Biosensing Techniques and Applications 2
- Advanced biosensing and bioanalysis techniques 1
-
- Monoclonal and Polyclonal Antibodies Research 5
- Co-authors
- Sabrina Oliveira (2 shared papers)Raymond M. Schiffelers (1 shared paper)Javier Sastre Toraño (1 shared paper)Cornelus F. van Nostrum (1 shared paper)Wim E. Hennink (1 shared paper)Paul M.P. van Bergen en Henegouwen (7 shared papers)Katerina T. Xenaki (3 shared papers)Bram Dorresteijn (1 shared paper)
- Journals
- Molecular Pharmaceutics (1 paper)Structure (1 paper)Journal of Controlled Release (1 paper)Life Science Alliance (1 paper)Theranostics (1 paper)
- Partner nations
- NetherlandsUnited StatesSouth Korea
In The Last Decade
Sofia Doulkeridou
9 papers receiving 247 citations
Peers
Comparison fields: 5 of 65
- Biomaterials 61
- Radiology, Nuclear Medicine and Imaging 83
- Immunology and Allergy 18
- Molecular Biology 149
- Pharmaceutical Science 13
Countries citing papers authored by Sofia Doulkeridou
This map shows the geographic impact of Sofia Doulkeridou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofia Doulkeridou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofia Doulkeridou more than expected).
Fields of papers citing papers by Sofia Doulkeridou
This network shows the impact of papers produced by Sofia Doulkeridou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofia Doulkeridou. The network helps show where Sofia Doulkeridou may publish in the future.
Co-authors
The 25 scholars most cited alongside Sofia Doulkeridou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 125 | |
| 2 | 2021 | 54 | |
| 3 | 2020 | 23 | |
| 4 | 2022 | 16 | |
| 5 | 2022 | 11 | |
| 6 | 2022 | 10 | |
| 7 | Middle East Respiratory Syndrome coronavirus (MERS-CoV): A Review | 2013 | 8 |
| 8 | 2024 | 3 | |
| 9 | 2022 | 1 |
About Sofia Doulkeridou
Sofia Doulkeridou is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Oncology, Biomaterials and Infectious Diseases, having authored 9 papers that have together received 251 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (5 papers), Glycosylation and Glycoproteins Research (3 papers), HER2/EGFR in Cancer Research (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Advanced Biosensing Techniques and Applications (2 papers), Advanced biosensing and bioanalysis techniques (1 paper), Cancer, Hypoxia, and Metabolism (1 paper) and Animal Virus Infections Studies (1 paper). The work is most often cited by research in Biomaterials (61 citations), Radiology, Nuclear Medicine and Imaging (83 citations), Immunology and Allergy (18 citations), Molecular Biology (149 citations) and Pharmaceutical Science (13 citations). Sofia Doulkeridou has collaborated with scholars based in Netherlands, United States and South Korea. Frequent co-authors include Sabrina Oliveira, Raymond M. Schiffelers, Javier Sastre Toraño, Cornelus F. van Nostrum, Wim E. Hennink, Paul M.P. van Bergen en Henegouwen, Katerina T. Xenaki, Bram Dorresteijn, B.J.C. Janssen and Niko Hildebrandt. Their work appears in journals such as Molecular Pharmaceutics, Structure, Journal of Controlled Release, Life Science Alliance and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.